Biomarkers as Key Contributors in Treating Malignant Melanoma Metastases
Melanoma is a human neurocristopathy associated with developmental defects in the neural crest-derived epidermal melanocytes. At the present time, at least three hypotheses were identified that may explain melanoma aetiology, as follows: (1) a model of linear progression from differentiated melanocy...
Main Authors: | Camila Ferreira de Souza, Alice Santana Morais, Miriam Galvonas Jasiulionis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Dermatology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/156068 |
Similar Items
-
Tracking and Treating Malignant Melanoma Metastases
by: Gérald E. Piérard, et al.
Published: (2012-01-01) -
miRNAs and Melanoma: How Are They Connected?
by: Adriana Taveira da Cruz, et al.
Published: (2012-01-01) -
Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
by: Fernanda Molognoni, et al.
Published: (2013-01-01) -
Correction: Ras and Rac1, frequently mutated in melanomas, are activated by superoxide anion, modulate Dnmt1 level and are causally related to melanocyte malignant transformation.
by: Fernanda Molognoni, et al.
Published: (2015-01-01) -
Malignant melanoma - cutaneous metastases
by: Padmavathy L, et al.
Published: (2008-01-01)